The future of phage therapy will be decided by more than science alone
Meeting Announcement
Updates every hour. Last Updated: 17-Jun-2026 09:15 ET (17-Jun-2026 13:15 GMT/UTC)
As antimicrobial resistance continues to threaten modern medicine, international experts will gather at Targeting Phage Therapy 2026 (Valencia, Spain, June 9–10, 2026) to address one of the most pressing questions in infectious disease research: how can phage therapy move from scientific promise to routine clinical practice?
The congress will bring together leading clinicians, researchers, regulators, biotechnology innovators and industry leaders to discuss the scientific, regulatory, manufacturing and clinical challenges shaping the future of bacteriophage-based therapies. Featuring 56 scientific communications, the meeting will explore personalized phage therapy, engineered phages, hospital implementation, GMP manufacturing, regulatory pathways and One Health applications. As antibiotic resistance continues to rise worldwide, the event aims to identify practical solutions that can accelerate the responsible integration of phage therapy into healthcare systems and improve patient access to innovative treatments.
Persistently low rates of COVID-19 vaccination in Black and Hispanic children suggest that parents in these communities tend to be hesitant about the vaccine for their kids, even when they have received it themselves. Through interviews with parents of school-aged children, a new study sheds light on the factors influencing decisions about vaccination. Findings were published in the June issue of the Vaccine: X journal.
A study of wetlands conservation policy in Florida and California suggests a way to reduce flood damage while retaining economic gains from development. The study recommends both an offset policy and a locally varying tax on development to compensate for increased flood risk.
Published today in Nature, researchers at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center report a previously unrecognized change in how the cell’s genetic material is packaged into structures called chromosomes, that helps explain how some aggressive cancers sustain unlimited growth.